Acute Renal Failure Clinical Trial
Official title:
Assessing the Impact of Two Methods of Continuous Veno-venous Hemodiafiltration on Time Nursing Work in Intensive Care
The prevalence of acute renal failure in intensive care is estimated at between 5 and 20%
depending on diagnostic criteria retained. And half of patients require the use of
hemodialysis. Continuous veno-venous hemodiafiltration (CVVHDF) is one of the hemodialysis
technique widely used in intensive care unit.
The CVVHDF is performed at the bedside, by a mobile generator with a semi permeable
membrane, a blood circuit, a dialysate circuit and a feedback circuit.
The implementation of a CVVHDF requires the use of large amounts of biological liquid
essential to enable the purification of blood during its passage through the artificial
kidney.
The objective of this study is to assess time nursing work and the costs of each method.
The prevalence of acute renal failure in intensive care is estimated at between 5 and 20%
depending on diagnostic criteria retained. And half of patients require the use of
hemodialysis. Continuous veno-venous hemodiafiltration (CVVHDF) is one of the hemodialysis
technique widely used in intensive care unit.
The CVVHDF is performed at the bedside, by a mobile generator with a semi permeable
membrane, a blood circuit, a dialysate circuit and a feedback circuit.
The implementation of a CVVHDF requires the use of large amounts of biological liquid
essential to enable the purification of blood during its passage through the artificial
kidney. The biological fluid may be supplied to the generator of CVVHDF in 2 ways:
- The conventional method, the most used: the generator operates with pockets containing
dialysis fluid, these pockets to be changed regularly by nurses
- The on-line method: the generator operates with a specific water system supplying the
dialysis fluid available in every room of the unit The objective of this study is to
assess time nursing work and the costs of each method.
For this, 15 patients will be included in this study. Each patient performs 12 hours of each
method (conventional and online), whose order will be randomized.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01946113 -
Mineral-Homeostasis in Continuous Renal Replacement Therapy
|
N/A | |
| Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A | |
| Terminated |
NCT00978354 -
Furosemide in Early Acute Kidney Injury
|
Phase 2/Phase 3 | |
| Completed |
NCT00120263 -
Trial of Plasma Exchange for Acute Renal Failure at the Onset of Myeloma
|
N/A | |
| Completed |
NCT04799600 -
The Effect of the Severity of COVID-19 Disease on the Incidence of Acute Renal Failure in ICU
|
||
| Recruiting |
NCT04334707 -
Kidney Precision Medicine Project
|
||
| Completed |
NCT02858531 -
Predictive Tracking of Patient Flow in the Emergency Services During the Virus Winter Epidemics
|
||
| Recruiting |
NCT05282732 -
Retrospective Analysis of Performance and Treatment Data Collected for Genius SleddFlux Filter, Ultraflux AV 600 S Filter & Genius 90 Concentrates in Haemodialysis Patients
|
||
| Completed |
NCT01467466 -
Prevention of Serious Adverse Events Following Angiography
|
Phase 3 | |
| Completed |
NCT01979042 -
Urinary Markers for Unilateral Kidney Obstruction
|
N/A | |
| Completed |
NCT01280617 -
Low Dose Thymoglobin in Renal Transplant Patients
|
N/A | |
| Completed |
NCT00780351 -
Dosing Vancomycin in Patients on Sustained Low Efficiency Daily Hemodiafiltration (SLEDD-f)
|
N/A | |
| Completed |
NCT00971971 -
Prevention of Intradialytic Hypotension in Acute Kidney Injury Patients
|
N/A | |
| Completed |
NCT00076219 -
Acute Renal Failure Trial Network (ATN) Study
|
Phase 3 | |
| Recruiting |
NCT04599569 -
Influence of Renal Replacement TherApy on Indirect Calorimetry
|
||
| Completed |
NCT03727204 -
Acute Kidney Injury After Cardiac Surgery: Novel Ultrasound Techniques for Prediction of Acute Kidney Injury
|
||
| Completed |
NCT06005896 -
A Clinical Model for Dialysis Discontinuation in AKI
|
||
| Completed |
NCT03004950 -
Biomarker Effectiveness Analysis in Contrast Nephropathy (BEACON)
|
||
| Completed |
NCT03627884 -
Outcomes of the Use of Sodium Bicarbonate (8.4%) Solution as a Catheter Lock Solution to Prevent Hemodialysis Catheter Loss Due to Lumen Clot Formation
|
Phase 4 | |
| Recruiting |
NCT04682236 -
Study of the Evolution Profile of the Renal Doppler in the Perioperative Hepathic Transplantation
|